Written question asked by Lord Mott (Conservative) on Tuesday, 14 July 2026, in the House of Lords. It was due for an answer on Tuesday, 28 July 2026. It was answered by Baroness Merron (Labour) on Monday, 20 July 2026 on behalf of the Department of Health and Social Care.
Prostate Cancer: Medical Treatments
- Question
-
To ask His Majesty's Government, further to the Written Statement by Baroness Merron on 2 June (HLWS82), which stated £2.8 million in capital funding will be made available to strengthen and expand provision of focal therapy for prostate cancer, what projects will be funded.
- Answer
-
The investment in focal therapies, announced on 2 June 2026, will strengthen existing provision in line with the expansion of the TRANSFORM trial for prostate cancer screening.
Any expansion of focal therapy provision to new sites will include appropriate clinical and market engagement. Officials at the Department are working closely with clinicians and researchers to optimise the planned investment of up to £2.8 million in focal therapy. Further details of this investment will be announced in due course.
Secondary information
- Type
- Written question
- Reference
- HL2086
- Session
- 2026-27
- Related items
- Subjects
- Finance Medical treatments Research Prostate cancer
- Contains statistics
- Yes
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-07-20 13:57:20 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2026-27/HL2086
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2026-27/HL2086
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2026-27/HL2086